MedTrace Logo MedTrace
Clinical Trials News Drugs Diseases Companies About

HER2-negative Breast Cancer

  1. Home
  2. Diseases
  3. HER2-negative Breast Cancer
  4. Clinical Trials

Clinical Trials Related to HER2-negative Breast Cancer

Related studies linked through entity extraction aliases.

NCT00194792

Hormone Therapy and Combination Chemotherapy Before and After Surgery in Treating Patients With Stage I-IIIA Breast Cancer

Status
TERMINATED
Phase
PHASE2

NCT00031681

7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007)

Status
COMPLETED
Phase
PHASE1

NCT00003440

Paclitaxel With or Without Trastuzumab in Treating Patients With or Without HER-2/Neu Breast Cancer That is Inoperable, Recurrent, or Metastatic

Status
COMPLETED
Phase
PHASE3
Previous

Next

Clinical Trials

Explore studies by the year of their last update.

  • 2026
  • 2025
  • 2024
  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011
  • 2010
  • 2009
  • 2008
  • 2007
  • 2006
  • 2005

News & Analysis

Latest news and insights on clinical trials and medical research.

Browse All News →
MedTrace Logo MedTrace
About Privacy Policy Terms of Service Medical Disclaimer

© 2026 MedTrace.
Open-access medical & pharmaceutical data intelligence.